Left Atrial Pressure Reduction for Mitral Stenosis Reverses Left Atrial Direction-dependent Conduction Abnormalities
Overview
Authors
Affiliations
Aims: Left atrial (LA) stretch-associated electrophysiological changes in patients with mitral stenosis (MS) predispose to atrial fibrillation. We hypothesized that the normalization of the pressure gradient by percutaneous transvenous mitral balloon valvotomy (PTMV) affects LA but not right atrial (RA) conduction, depending on the site of stimulation. Because direction-dependent (asymmetric) changes of conduction may contribute to arrhythmogenesis, we assessed conduction symmetry in MS patients and tested whether it is restored by PTMV.
Methods And Results: In nine patients with MS, atrial effective refractory period and local activation times (ATs) were determined during stimulation before and after PTMV, with up to four decapolar catheters (LA and RA). Eight patients with ventricular pre-excitation served as controls. ATs at basic cycle length were similar before and after PTMV. With stimulation from either atrium, they were about 45 ms in the ipsilateral atrium and about 115 ms in the contralateral atrium. With premature stimulation, ATs increased dramatically. The shortest ATs were found in the RA with RA stimulation (78 +/- 9 and 80 +/- 6 ns, before and after PTMV). PTMV caused a shortening in LA-ATs (following LA stimulation) from 118 +/- 14 to 82 +/- 5 ms (before and after; P < 0.05). Asymmetry in conduction properties was therefore normalized by PTMV. PTMV led to a decrease in RA-ATs (following LA stimulation) from 196 +/- 11 to 174 +/- 13 ms (P < 0.02). In addition, following RA stimulation, the dispersion in ATs in the LA decreased significantly by PTMV (from 66 +/- 10 to 34 +/- 7 ms; P < 0.02).
Conclusion: MS is associated with LA conduction delay, increased LA dispersion of conduction, and conduction asymmetry. These changes are immediately reversible by PTMV.
Celotto C, Sanchez C, Abdollahpur M, Sandberg F, Rodriguez Mstas J, Laguna P Front Physiol. 2024; 14:1189464.
PMID: 38235381 PMC: 10791938. DOI: 10.3389/fphys.2023.1189464.
Pearce N, Kim E Bioengineering (Basel). 2022; 9(9).
PMID: 36135000 PMC: 9495401. DOI: 10.3390/bioengineering9090454.
Yan Y, Skarsfeldt M, Diness J, Bentzen B Int J Cardiol Heart Vasc. 2021; 37:100898.
PMID: 34746364 PMC: 8554272. DOI: 10.1016/j.ijcha.2021.100898.
Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar.
Gottlieb L, Al Jefairi N, El Hamrani D, Naulin J, Lamy J, Kachenoura N Int J Cardiol Heart Vasc. 2021; 37:100894.
PMID: 34746362 PMC: 8554268. DOI: 10.1016/j.ijcha.2021.100894.
Lin H, Lin T, Lin L, Ye M Med Sci Monit. 2020; 26:e924418.
PMID: 33075040 PMC: 7583546. DOI: 10.12659/MSM.924418.